Aus CVD risk: the Australian cardiovascular disease risk calculator

The 2023 Aus CVD Risk calculator and guideline provide updated evidence-based recommendations for identifying, assessing, communicating and managing CVD risk in a primary prevention setting.

Fluoxetine: can it decrease weight in obese and overweight patients?

This evidence summary presents the best available evidence on the effectiveness of fluoxetine in decreasing weight.

Giving a voice back to elderly patients

Yesterday’s National Medicine Symposium delivered a stark critique of how our health system is failing older patients – and how to fix it.

Understanding the barriers to RMMRs

Residential medication management reviews have proven to be beneficial in identifying medicine-related problems, so why are they so under-utilised?

ATAGI highlights progress amid resurgent diseases

ATAGI flagged worrying vaccine coverage declines and renewed disease threats, with pharmacists tipped to boost community protection.

Career pathways: Academic and asthma educator

Having missed out on studying medicine at the university of her choice in India, Associate Professor Bandana Saini MPS thought she’d study pharmacy for...